Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits

Documenta Ophthalmologica

Volumn 110, Issue 1, 2005, Pages 37-55

  Harrison, Joseph M ^a   Glickman, Randolph D ^a   Ballentine, Charles S ^a   Trigo, Yolanda ^a   Pena, Melanie A ^a   Kurian, Pearl ^a   Najvar, Laura K ^a   Kumar, Neeru ^a   Patel, Ankit H ^a   Sponsel, William E ^a   Graybill, John R ^a   Lloyd III, William C ^a   Miller, Margaret M ^a   Paris, Gianmarco ^a   Trujillo, Fernando ^a   Miller, Aaron ^a   Melendez, Robert ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Amphotericin B; Aspergillus fumigatus; Electroretinogram; Endophthalmitis micafungin; Voriconazole

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; MICAFUNGIN; NEW DRUG; SODIUM CHLORIDE; VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; B WAVE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; EYE INFECTION; FUNCTIONAL ASSESSMENT; NONHUMAN; RABBIT; RETINA;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; FOLLOW-UP STUDIES; LIPOPROTEINS; OPHTHALMOSCOPY; PEPTIDES, CYCLIC; PYRIMIDINES; RABBITS; RETINA; TRIAZOLES; VITREOUS BODY;

EID: 30344475503     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-005-7342-0     Document Type: Article

References (56)

1. Cannon JP, Fiscella R, Pattharachayakul S, Garey SW, Alba De F, Piscitelli S, Edward DP, Danziger LH. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model. Invest Ophthalmol Vis Sci 2003; 44: 2112-2117 10.1167/ iovs.02-1020 12714650
2. Pawlitz D, Young M, Klepser M. Micafungin: A new echinocandin antifungal. Formulary 2003; 38: 354-367.
3. Ikeda F, Wakai Y, Matsumoto S, Maki K, Watabe E, Tawara S, Goto T, Watanabe Y, Matsumoto F, Kuwahara S Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis. Antimicrob Agents Chemother 2000; 44: 614-618. 10.1128/ AAC.44.3.614-618.2000 10681327
4. Petraitis V, Petraitiene R, Groll AH, Roussillon K, Hemmings M, Lyman CA, Sein T, Bacher J, Bekersky I, Walsh TJ. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob Agents Chemother 2002; 46: 1857-1869. 10.1128/AAC.46.6.1857-1869.2002 12019101
5. Warn PA, Morrissey G, Morrissey J, Denning DW. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B. J Antimicrob Chemother 2003; 51: 913-919. 10.1093/jac/dkg185 12654746
6. Graybill JR, Bocanegra R, Gonzalez GM, Najvar LK. Combination antifungal therapy of murine aspergillosis: Liposomal amphotericin B and micafungin. J Antimicrob Chemother 2003; 52: 656-662. 10.1093/jac/dkg425 12972452
7. Maki K, Morishita Y, Iguchi Y, Watabe E, Otomo K, Teratani M, Watanabe Y, Ikeda F, Tawara S, Goto T, Tomishima M. In vitro antifungal activity of FK463, a novel water-soluble echinocandin-like lipopeptide. Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology 2004; Abstract F142
8. Luque JC, Clemons KV, Stevens DA. Efficacy of micafungin alone or in combination against systemic murine aspergillosis. Antimicrob Agents Chemother 2003; 47: 1452-1455 10.1128/AAC.47.4.1452-1455.2003 12654692
9. Beauvais A, Bruneau JM, Mol PC, Buitrago MJ, Legrand J, Latge JP. Glucan synthase complex of Aspergillus fumigatus. J Bacteriol 2001; 183: 2273-2279. 10.1128/JB.183.7.2273-2279.2001 11244067
10. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 2002; 12: 310-350. 10194462
11. Bowman JC, Hicks PS, Kurtz MB, Rosen H, Schmatz DM, Liberator PA, Douglas CM. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob Agents Chemother 2002; 46: 3001-3012. 10.1128/AAC.46.9.3001-3012.2002 12183260
12. Mochizuki K, Torisaki M, Kawasaki K, Shirao Y, Yamashita Y, Kitano K, Yonemura D Retinal toxicity of antibiotics: Evaluation by electroretinogram. Doc Ophthalmol 1998; 69: 195-202. 10.1007/BF00153701 3168722
13. Jain VK, Dawson WW, Engel HM, Rubin ML. Electroretinograms in early fungal endophthalmitis. Doc Ophthalmol 1998; 69: 227-235. 10.1007/ BF00154403 3048943
14. Baldinger J, Doft BH, Burns SA, Johnson B. Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes. Br J Ophthalmol 1986; 70: 657-661. 3756121
15. O'Hara MA, Bode DD, Kincaid MC, Harrison JM, Perkins MS. Retinal toxicity of intravitreal cefoperazone. J Ocul Pharmacol 1986; 2: 177-184. 3503106
16. Dolnak DR, Munguia D, Wiley CA, De Clercq E, Bergeron-Lynn GL, Boscher C, Connor JD, Sherwood C, Capparelli E, Armani R. Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine. Invest Ophthalmol Vis Sci 1992; 33: 1557-1563. 1559752
17. Pulido J, Peyman GA, Lesar T, Vernot J. Intravitreal toxicity of hydroxyacyclovir (BW-B759U), a new antiviral agent. Arch Ophthalmol 1985; 103: 840-841. 3873931
18. Shockley RK, Jay WM, Friberg TR, Aziz AM, Rissing JP, Aziz MZ. Intravitreal ceftriaxone in a rabbit model. Dose- and time-dependent toxic effects and pharmacokinetic analysis. Arch Ophthalmol 1984; 102: 1236-1238. 6087776
19. Grown GC, Eagle RC, Shakin EP, Gruber M, Arbizio VV. Retinal toxicity of intravitreal gentamicin. Arch Ophthalmol 199; 108: 1740-1744. 2256847
20. Harrison JM, van Heuven WA. Retinal pigment epithelial dysfunction in human immunodeficiency virus-infected patients with cytomegalovirus retinitis. Ophthalmology 1999; 106: 790-797. 10.1016/ S0161-6420(99)90168-9 10201604
21. Story JL, Held KS, Harrison JM, Cleland TP, Eubanks KD, Brown Jr. WE. The ocular ischemic syndrome in carotid artery occlusive disease: ophthalmic color Doppler flow velocity and electroretinographic changes following carotid artery reconstruction. Surg Neurol 1995; 44: 534-535. 10.1016/0090-3019(95)00368-1 8669026
22. Sauve Y, Lu B, Lund RD. The relationship between full field electroretinogram and perimetry-like visual thresholds in RCS rats during photoreceptor degeneration and rescue by cell transplants. Vision Res 2004; 44: 9-18. 10.1016/j.visres.2003.08.015 14599567
23. Block F, Schwarz M, Sontag KH. Retinal ischemia induced by occlusion of both common carotid arteries in rats as demonstrated by electroretinography. Neurosci Lett 1992; 144: 124-126. 10.1016/ 0304-3940(92)90731-L 1436691
24. Gresh J, Goletz PW, Crouch RK, Rohrer B. Structure-function analysis of rods and cones in juvenile, adult, and aged C57bl/6 and Balb/c mice. Vis Neurosci 2003; 20: 211-220. 10.1017/S0952523803202108 12916741
25. Lin J, Roth S. Ischemic preconditioning attenuates hypoperfusion after retinal ischemia in rats. Invest Ophthalmol Vis Sci 1999; 40: 2925-2931. 10549654
26. Roth S, Li B, Rosenbaum PS, Gupta H, Goldstein IM, Maxwell KM, Gidday JM. Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci 1998; 39: 777-785. 9538885
27. Masuda K, Watanabe I, Unoki K, Ohba N, Muramatsu T. Functional Rescue of photoreceptors from the damaging effects of constant light by survival-promoting factors in the rat. Invest Ophthal Vis Sci 1995; 36: 2142-2146. 7657551
28. Bush RA, Kononen L, Machida S, Sieving PA. The effect of calcium channel blocker diltiazem on photoreceptor degeneration in the rhodopsin Pro213His rat. Invest Ophthalmol Vis Sci 2000; 41: 2697-2701. 10937585
29. Sugawara T, Sieving PA, Bush RA. Quantitative relationship of the scotopic and photopic ERG to photoreceptor cell loss in light damaged rats. Exp Eye Res 2000; 70: 693-705. 10.1006/exer.2000.0842 10870528
30. Bowers F, Valter K, Chan S, Walsh N, Maslim J, Stone J. Effects of oxygen and bFGF on the vulnerability of photoreceptors to light damage. Invest Ophthalmol Vis Sci 2001; 42: 804-815. 11222544
31. Ranchon I, Chen S, Alvarez K, Anderson RE. Systemic administration of phenyl-N-tert-butylnitrone protects the retina from light damage. Invest Ophthalmol Vis Sci 2001; 42: 1375-1379. 11328754
32. Cao W, Tombran-Tink J, Elias R, Sezate S, Mrazek D, McGinnis JF. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2001; 42: 1646-1652. 11381073
33. Nir I, Harrison JM, Liu C, Wen R. Extended photoreceptor viability by light stress in the RCS rats but not in the opsin P23H mutant rats. Invest Ophthalmol Vis Sci 2001; 42: 842-849. 11222548
34. Machida S, Chaudhry P, Shinohara T, Singh SP, Reddy VN, Chylack LT Jr., Sieving PA, Bush RA. Lens epithelium-derived growth factor promotes photoreceptor survival in light-damaged and RCS rats. Invest Ophthalmol Vis Sci 2001; 42: 1087-1095. 11274090
35. Mizota A, Sato E, Taniai M, Adachi-Usami E, Nishikawa M. Protective effects of dietary docosahexaenoic acid against kainate-induced retinal degeneration in rats. Invest Ophthalmol Vis Sci 2001; 42: 216-221. 11133871
36. Lau D, McGee LH, Zhou S, Rendahl KG, Manning WC, Escobedo JA, Flannery JG. Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci 2000; 41: 3622-3633. 11006261
37. Li F, Cao W, Anderson RE. Protection of photoreceptor cells in adult rats from light-induced degeneration by adaptation to bright cyclic light. Exp Eye Res 2001; 73: 569-577. 10.1006/exer.2001.1068 11825027
38. Machida S, Kondo M, Jamison JA, Khan NW, Kononen LT, Sugawara T, Bush RA, Sieving PA. P23H rhodopsin transgenic rat: Correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci 2000; 41: 3200-3209. 10967084
39. Ghannoum MA, Rice LB. Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999; 12: 501-517. 10515900
40. Le Grand Y. Light, Colour, and Vision Chapman and Hall Ltd. London., 1968.
41. Marmor MF, Zrenner E. Standard for clinical electroretinography (1999 update). International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol 1998; 97: 143-156. 10.1023/A:1002016531591 10765968
42. Groll AH, Mickiene D, Petraitis V, Petraitiene R, Ibrahim KH, Piscitelli SC, Bekersky I, Walsh TJ. Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits. Antimicrob Agents Chemother 2001; 45: 3322-3327. 10.1128/AAC.45.12.3322-3327.2001 11709303
43. Eldem T, Arican-Cellat N, Agabeyoglu I, Akova M, Kansu E. Pharmacokinetics of liposomal amphotericin B in neutropenic cancer patients. Int J Pharm 2001; 213: 153-161. 10.1016/S0378-5173(00)00663-3 11165103
44. Zhou L, Glickman RD, Chen N, Sponsel WE, Graybill JR, Lam WE. determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 776: 213-220. 12138003
45. Bush RA, Lei B, Tao W, Raz D, Chan CC, Cox TA, Santos-Muffley M, Sieving PA. Encapsulated cell-based intraocular delivery of ciliary neurotrophic factor in normal rabbit: Dose-dependent effects on ERG and retinal histology. Invest Ophthalmol Vis Sci 2004; 45: 2420-2430. 10.1167/iovs.03-1342 15223826
46. Birch DG, Anderson JL. Standardized full-field electroretinography. Normal values and their variation with age. Arch Ophthalmol 1992; 110: 1571-1576. 1444914
47. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Villard O, Liu KL, Natarajan-Ame S, Lutz P, Dufour P, Bergerat JP, Candolfi E. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898-1906. 10.1200/JCO.2002.07.004 11919250
48. Prince JH, McConnell DG. Retina and optic nerve, The rabbit in eye research. In: Prince JH ed. The rabbit in eye research, Springfield, Illinois: Thomas C. Charles, 1964: 385-415.
49. Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature. Mycopathologia 2001; 150: 101-115. 10.1023/ A:1010954803886 11469757
50. Marco F, Pfaller MA, Messer SA, Jones RN. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. Med Mycol 1998; 36: 433-436. 10.1046/j.1365-280X.1998.00170.x 10206756
51. Gao H, Pennesi ME, Shah K, Qiao X, Hariprasad S, Mieler WF, Wu SM, Holz ER. Safety of intravitreal voriconazole: Electroretinographic and histophathologic studies. Trans Am Ophthalmol Soc 2003; 101: 183-189. 14971576
52. Herbrecht R, Denning SW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw E. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-415. 10.1056/NEJMoa020191 12167683
53. Harrison JM, O'Connor PS, Young RS, Kincaid M, Bentley R. The pattern ERG in man following surgical resection of the optic nerve. Invest Ophthal Vis Sci (Suppl) 1987; 28: 492-499.
54. Holopigian K, Greenstein VC, Seiple W, Hood DC, Ritch R. Electrophysiologic assessment of photoreceptor function in patients with primary open-angle glaucoma. J Glaucoma 2000; 9: 163-168. 10782626
55. Dong CJ, Hare WA. Contribution to the kinetics and amplitude of the electroretinogram b-wave by third-order retinal neurons in the rabbit retina. Vision Res 2000; 40: 579-589. 10.1016/S0042-6989(99)00203-5 10824262
56. Wurziger K, Lichtenberger T, Hanitzsch R. On-bipolaar cells and depolarising thirs-order neurons as the origin of the ERG-b-wave inthe RCS rat. Vision Res 2001; 41: 1091-1101.